References
- Bassani DG, Kumar R, Awasthi S, Morris SK, Paul VK, Million Death Study Collaborators, et al. Causes of neonatal and child mortality in India: a nationally representative mortality survey. Lancet. 2010;376(9755):1853–60.
- National Operational Guidelines for Introduction of Measles-Rubella Vaccine (Campaign and Routine Immunization). New Delhi (India): Ministry of Health & Family Welfare Government of India; 2016.
- World Health Organization, Regional Office for South-East Asia. Strategic plan for measles elimination and rubella and congenital rubella syndrome control in the South-East Asia Region, 2014-2020. 2015 [cited 2020 30 May]. https://apps.who.int/iris/handle/10665/205923 .
- Murhekar M, Verma S, Singh K, Bavdekar A, Benakappa N, Santhanam S, Sapkal G, Viswanathan R, Singh MP, Nag VL, et al. Epidemiology of Congenital Rubella Syndrome (CRS) in India, 2016-18, based on data from sentinel surveillance. PLoS Negl Trop Dis. 2020;14(2):e0007982. doi:10.1371/journal.pntd.0007982.
- Muliyil DE, Singh P, Jois SK, Otiv S, Suri V, Varma V, Abraham AM, Raut C, Gupta M, Singh MP, et al. Sero-prevalence of rubella among pregnant women in India, 2017. Vaccine. 2018;36(52):7909–12. doi:10.1016/j.vaccine.2018.11.013.
- ThinkWell. Immunization Delivery Costs in Low- and Middle-Income Countries: a descriptive analysis, gap analysis, and summary of immunization delivery unit costs in the literature. 2020 [cited 2021 16 Feb]. https://static1.squarespace.com/static/556deb8ee4b08a534b8360e7/t/5e4e9418dbed0d592f94d8bf/1582208033613/1.+ICAN+Summary+Report_29January20.pdf .
- Gandhi G, Lydon P. Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts. BMC Public Health. 2014;14(1):67. doi:10.1186/1471-2458-14-67.
- Measles & Rubella Initiative. South-East Asia Plans to Eliminate Measles by 2020. 2013 [cited 2020 July 15]. https://measlesrubellainitiative.org/measles-news/south-east-asia-plans-eliminate-measles-2020/ .
- Gavi. Guidelines for Applications for Measles and Rubella vaccines under Gavi’s New and underused Vaccines Support (NVS) in 2017. 2016 [cited 2020 July 17]. https://www.gavi.org/sites/default/files/temp/gavi_1570474824/English/2017%20Guidelines%20for%20applications%20for%20Measles%20Rubela_Final_Feb17.pdf .
- Kar SK, Sah B, Patnaik B, Kim YH, Kerketta AS, Shin S, Rath SB, Ali M, Mogasale V, Khuntia HK, et al. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model. PLoS Negl Trop Dis. 2014;8(2):e2629. doi:10.1371/journal.pntd.0002629.
- Census of India 2011. Office of the Registrar General & Census Commissioner, India Ministry of Home Affairs, Government of India. 2011 [cited 2021 18 April]. https://censusindia.gov.in/DigitalLibrary/Archive_home.aspx .
- Gavi. India: gavi support. 2020 [cited 2020 July 15]. https://www.gavi.org/programmes-impact/country-hub/south-east-asia/india .
- Chokshi M, Patil B, Khanna R, Neogi SB, Sharma J, Paul VK, Zodpey S. Health systems in India. J Perinatol. 2016;36(s3):S9–S12. doi:10.1038/jp.2016.184.
- Vaughan K, Ozaltin A, Mallow M, Moi F, Wilkason C, Stone J, Brenzel L. The costs of delivering vaccines in low- and middle-income countries: findings from a systematic review. Vaccine: X. 2019;2:100034. doi:10.1016/j.jvacx.2019.100034.
- How to cost immunization programs: a practical guide on primary data collection and analysis: EPIC Project; 2020 [cited 2020 Nov 5]. http://immunizationeconomics.org/costingmethods .
- Universal Immunization Programme. Comprehensive Multi-Year Plan −2018-22. Ministry of Health and Family Wlefare, Government of India; 2018 [cited 2020 Jul 7]. https://nhm.gov.in/New_Updates_2018/NHM_Components/Immunization/Guildelines_for_immunization/cMYP_2018-22_final_pdf.